Director, US Health Economics and Outcomes Research
GSK
Disclosure(s): GSK: employee, Stocks/Bonds (Public Company)
David Singer, PharmD, MS, is Director, US Health Economics and Outcomes Research at GSK where he is responsible for real-world evidence generation relating to respiratory syncytial virus (RSV). His research includes retrospective database and modeling studies evaluating the clinical and economic burden of RSV as well as the value and impact of RSV vaccination. Prior to joining GSK, Dr. Singer was an Associate Director, Health Economics and Outcome Research at Boehringer Ingelheim Pharmaceuticals, Inc. where he led health outcomes research and conducted economic analyses relating to specialty medicines and primary care. His research has been published in a number of peer-reviewed journals and presented at various professional conferences.